Georg Hutarew

Dr. Georg Hutarew is a researcher at the Department of Pathology at Salzburg General Hospital (Salzburger Landeskliniken). With over two decades of active research from 2001 to 2024, he has contributed 52 research outputs including original articles, case reports, and abstracts. His work primarily focuses on molecular pathology with emphasis on cancer epigenetics and diagnostics.

Dr. Hutarew's research interests center on DNA methylation patterns in various cancers, particularly examining relationships between methylation status, PD-L1 expression, and tumor characteristics in lung cancer, breast cancer, and glioblastoma. His work frequently employs advanced molecular techniques including droplet digital PCR for precise biomarker quantification and DNA methylome profiling for comprehensive epigenetic analysis.

Analysis of his recent publications reveals a strong focus on the intersection of molecular pathology and cancer therapeutics. His research demonstrates expertise in EGFR-amplified glioblastoma, HER2 testing in breast cancer using droplet digital PCR, and methylation analysis in non-small cell lung cancer with varying PD-L1 expression. These studies contribute significantly to precision oncology by developing more accurate diagnostic methods and understanding epigenetic mechanisms driving cancer progression.

Dr. Hutarew has established productive collaborations with researchers including Alinger-Scharinger B., Sotlar K., and Kraus T.F.J., resulting in numerous co-authored publications in high-impact journals such as Cancers and Virchows Archiv. His work has been cited in the scientific literature and disseminated through academic platforms like Mendeley.